Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1
Andrew L. Mammen(Malaysian Society of Nephrology), James L. Gulley(National Cancer Institute), Αναστασία Ζεκερίδου(Mayo Clinic), Raffit Hassan(National Cancer Institute), Tanya Lehky(National Institutes of Health), Renee N. Donahue(National Institutes of Health), Jeffrey Schlom(National Cancer Institute), Katherine Pak(National Institutes of Health), Arun Rajan(National Cancer Institute), Lauren M. Lepone(National Institutes of Health), Sean J. Pittock(Mayo Clinic), Livia Casciola‐Rosen(Johns Hopkins University)
Cited by 134
Related Papers
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
Revised diagnostic criteria for neuromyelitis optica
|Neurology|2006|2.6k
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
|The Journal of Experimental Medicine|2005|2.3k
The spectrum of neuromyelitis optica
|The Lancet Neurology|2007|2.2k
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
|The Journal of Experimental Medicine|2006|1.7k